St. Louis Post-Dispatch: Mallinckrodt turned an old drug into a ‘cash cow,’ pumping price to $40,000 a vial, emails show

He argued that Mallinckrodt had invested $660 million in improving manufacturing of the drug and in seeking evidence that Acthar works for many other uses that the FDA permits.
Rep. Jimmy Gomez, D-California, said Trudeau’s answer misled the committee and he owed Maloney an apology.
“Replacing one term with another term, ‘cash cow’ with ‘profit maximizer,’ doesn’t change the intent of your company, which is to make as much money as possible,” Gomez said.

Full Article

Stay Connected

Use the form below to sign up for my newsletter and get the latest news and updates directly to your inbox.